Hsien-chi Fan
Taoyuan, TNQ 33305, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma" [Translational Oncology, Volume 65, March 2026, 102670].
Journal: Translational oncology
Published: April 18, 2026
SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma.
Journal: American journal of cancer research
Published: December 25, 2025
Androgen receptor may promote tumor progression via TTF-1/EGFR pathway in metastatic nasopharyngeal carcinoma.
Journal: Translational oncology
Published: August 23, 2025
Characterization of the immune cell profile in metastatic nasopharyngeal carcinoma treated with chemotherapy and immune checkpoint inhibitors.
Journal: American journal of cancer research
Published: October 29, 2024
A patient-derived xenograft mouse platform from epithelioid glioblastoma provides possible druggable screening and translational study.
Journal: American journal of cancer research
Published: May 01, 2024
Paraneoplastic leukocytosis induces NETosis and thrombosis in bladder cancer PDX model.
Journal: American journal of cancer research
Published: February 11, 2024
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways.
Journal: Translational oncology
Published: July 05, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026